Tag : Myeloma

Biology

Long Noncoding RNA H19 Promotes Tumorigenesis of Multiple Myeloma by Activating BRD4 Signaling by Targeting MicroRNA 152-3p [Research Article]

Newsemia
Multiple myeloma (MM) accounts for over twenty percent of hematological cancer-related death worldwide. Long noncoding RNA (lncRNA) H19 is associated with multiple tumorigenesis and is...
Gastroenterology

Researchers discover a way to move precision immunotherapy forward for multiple myeloma

Newsemia
Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way to move precision immunotherapy forward by using genomics to inform immunotherapy...
Latest News

Janssen Presents Initial Results for BCMA CAR-T Therapy JNJ-4528 Showing Early, Deep and High Responses in the Treatment of Relapsed or Refractory Multiple Myeloma

Newsemia
BEERSE, Belgium–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson announced today initial results from the Phase 1b/2 CARTITUDE-1 study (NCT03548207) evaluating the efficacy and...
Neurology

Phase 2 clinical trial of CAR T-cell therapy starts at Atlantic Health System

Newsemia
Atlantic Health System is treating patients in a new Phase 2 clinical trial of CAR T-cell therapy at Morristown Medical Center. A select number of...
Latest News

Exposure to 9/11 WTC dust associated with increased risk of heart disease in NYC firefighters

Newsemia
A new study of New York City firefighters has found that exposure to 9/11 World Trade Center dust is associated with a significantly increased long-term...
Latest News

Another myeloma drug with same target as CAR-Ts shows successful Phase II results

Newsemia
Without providing details, GlaxoSmithKline said its trial of BCMA-targeting belantamab mafodotin was positive. The company plans to submit for regulatory approvals later this year –...
Latest News

New therapy found to be effective for patients with a particular type of bone marrow cancer

Newsemia
Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is...
Latest News

Study Investigating Darzalex®▼ (daratumumab) Shows Improved Depth of Response and Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Who are Eligible for a Transplant

Newsemia
BEERSE, Belgium–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the Phase 3 CASSIOPEIA (MMY3006, NCT02541383) study, an Intergroupe Francophone du...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy